MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
567
Unique beneficiaries
—
Total services
5,844
Distinct HCPCS
9
Medicare payment
$262K
Peer benchmark
Total Medicare services vs. 132 Allergy/ Immunology providers in NJ — top quintile (cohort median 3,350).
PRESCRIBING · PART D · 2024
Total Rx claims
961
Beneficiaries
—
Total drug cost
$397K
Distinct drugs
16
Brand share
47.2%
Top prescribed drugs
Montelukast Sodium148 claims
Fluticasone Propionate140 claims
Albuterol Sulfate112 claims
Fluticasone/Umeclidin/Vilanter104 claims
Fluticasone/Vilanterol61 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$178K
Payment records
141
By payment type
Consulting Fee$144K
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$29K
Travel and Lodging$3K
Food and Beverage$2K
Education$19
Top paying entities
Consulting Fee$144K
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$29K
Travel and Lodging$3K
Food and Beverage$2K
Education$19
REFERRAL NETWORK
Where John Oppenheimer's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| AHS HOSPITAL CORP. | 84 | 412 |
| Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ | 26 | 85 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE